OBJECTIVE: The purpose of this study was to test whether omitting the vasod
ilator nitric oxide that is derived from any 1 of the 3 isoforms of nitric
oxide synthase results in hypertension during pregnancy.
STUDY DESIGN: We measured systolic blood pressure before, during, and after
pregnancy using an automated tail cuff method in 3 mutant (gene knockout)
mouse strains in which the gene for neuronal nitric oxide, inducible nitric
oxide, or endothelial nitric oxide was disrupted by gene targeting.
RESULTS: In neuronal nitric oxide gene knockout mice (n = 10), blood pressu
re was 100 +/- 3 mm Hg, not significantly different from 101 +/- 3 mm Hg in
matched wild-type control mice (n = 10). Pregnancy did not change blood pr
essure or heart rate in either group. In inducible nitric oxide gene knocko
ut mice (n = 9), blood pressure was 110 +/- 3 mm Hg, the same as in the wil
d-type control mice (110 +/- 2 mm Hg; n = 14). Blood pressure was unaffecte
d by pregnancy in either group of mice. However, heart rate was significant
ly less in knockout mice (647 +/- 11 beats/min vs 666 +/- 9 beats/min; P <
.005); this difference persisted through pregnancy. In endothelial nitric o
xide gene knockout mice (n = 8), blood pressure was higher before pregnancy
(114 +/- 4 mm Hg vs 103 +/- 4 mm Hg; P < .05) than in wild-type control mi
ce (n = 9), but this difference disappeared during pregnancy, returning onl
y after delivery. Heart rates were not different before pregnancy and were
unaffected by pregnancy.
CONCLUSION: There was no apparent increase in systolic blood pressure in an
y of the 3 nitric oxide synthase gene knockout strains during pregnancy com
pared to the wild-type control mice. This suggests that, at least in the mo
use, genetic deficiency of any 1 isoform of nitric oxide synthase does not
result in pregnancy-induced hypertension.